Position in HROW
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,395,902
+$393,558 QoQ
Shares Held
56,414
-0.7% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#49
of 223 holders
Holding Since
Jun 2022
15 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $43,412,538 across 29 Drug Manufacturers - Specialty & Generic names. HROW ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
121,151 | $8,705,910 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
45,360 | $7,644,974 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9,855 | $5,339,734 | |
| 4 | VTRS |
Viatris Inc
|
197,717 | $3,139,745 | |
| 5 | HLN |
Haleon plc
|
263,202 | $2,455,674 | |
| 6 | HROW |
Harrow, Inc.
This page
|
56,414 | $2,395,902 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
143,998 | $2,308,287 | |
| 8 | ALKS |
Alkermes plc.
|
42,278 | $2,215,367 |
All Filings in HROW
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,395,902 | 56,414 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,002,344 | 56,788 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,427,991 | 69,959 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,352,508 | 69,583 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $2,317,039 | 75,869 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,017,556 | 75,848 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,446,466 | 72,920 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,827,849 | 85,139 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,962,699 | 93,954 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,242,879 | 93,944 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $115,158 | 10,282 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,581 | 458 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $337,902 | 17,747 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $8,675 | 410 | Shares | Sole | 2023-05-15 | |
| 2022-06-30 | $50,960 | 7,000 | Shares | Sole | 2022-08-23 | |
| No filing history on record for this holder in this stock. | ||||||